Ultragenyx Pharmaceutical shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Ultragenyx Pharmaceutical by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $5.7M | 118k | 47.82 |
2023-09-30 | $4.1M | 115k | 35.65 |
2023-06-30 | $4.2M | 106k | 40.10 |
2023-03-31 | $4.2M | 106k | 40.10 |
2022-12-31 | $5.6M | 122k | 46.33 |
2022-09-30 | $4.1M | 99k | 41.41 |
2022-06-30 | $6.8M | 115k | 59.66 |
2022-03-31 | $8.4M | 115k | 72.62 |
2021-12-31 | $8.7M | 104k | 84.09 |
2021-09-30 | $8.4M | 93k | 90.19 |
2021-06-30 | $9.1M | 95k | 95.35 |
2021-03-31 | $8.3M | 73k | 113.86 |
2020-12-31 | $5.4M | 65k | 82.19 |
2020-09-30 | $5.4M | 65k | 82.19 |
2020-06-30 | $4.7M | 60k | 78.22 |
2020-03-31 | $2.7M | 60k | 44.43 |
2019-12-31 | $2.5M | 59k | 42.71 |
2019-09-30 | $2.5M | 58k | 42.78 |
2019-06-30 | $3.1M | 48k | 63.50 |
2019-03-31 | $3.0M | 44k | 69.36 |
2018-12-31 | $1.5M | 35k | 43.48 |
2018-09-30 | $2.6M | 34k | 76.34 |
2018-06-30 | $2.5M | 33k | 76.87 |
2018-03-31 | $1.7M | 33k | 50.99 |
2017-12-31 | $1.2M | 27k | 46.38 |
2017-09-30 | $1.3M | 25k | 53.26 |
2017-06-30 | $1.5M | 24k | 62.11 |
2017-03-31 | $1.3M | 20k | 67.78 |
2016-12-31 | $893k | 13k | 70.27 |
2016-09-30 | $1.5M | 21k | 71.05 |
2016-06-30 | $963k | 20k | 48.99 |
2016-03-31 | $770k | 12k | 63.29 |
2015-12-31 | $6.7M | 60k | 112.17 |
2015-09-30 | $5.9M | 61k | 96.31 |
2015-06-30 | $983k | 9.6k | 102.40 |
2015-03-31 | $503k | 8.1k | 62.10 |
2014-12-31 | $202k | 4.6k | 43.91 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas